Hydroxyapatite/silk Fibroin Composite Microspheres Loaded with Methotrexate for Repairing Giant Cell Tumor-Associated Bone Defects
Zhai Qingpan,Zhu Caihong,Li Bin
DOI: https://doi.org/10.3389/conf.fbioe.2016.01.02503
IF: 5.7
2016-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Event Abstract Back to Event Hydroxyapatite/silk fibroin composite microspheres loaded with methotrexate for repairing giant cell tumor-associated bone defects Qingpan Zhai1, Caihong Zhu1 and Bin Li1, 2 1 Soochow University, Orthopedic Institute, China 2 The First Affiliated Hospital of Soochow University, Department of Orthopaedics, China Introduction: Chemotherapy is commonly used after surgical resection of giant cell tumor to prevent its recurrence. Filling with osteogenic material together with chemotherapy drugs in tumor cavity is a promising way to eliminate tumor cells and promote new bone formation simultaneously. In this study, we prepared osteogenic hydroxyapatite (HA) and silk fibroin (SF) complex microspheres and used them as a drug delivery system. In order to reduce the burst release and extend the drug release time, the HA/SF microspheres were coated with polylactic acid (PLLA). Materials and Methods: Ca(NO3)2 was added into an 8% silk fibroin(SF) aqueous solution (Solution A, pH=9). Methotrexate (MTX) was added into a (NH4)2HPO4 aqueous solution (Solution B, pH=9). The solutions A and B were added dropwise into paraffin successively under continuous stirring to prepare MTX-loaded HA/SF microspheres (MTX/HA/SF). Following that, the microspheres were added into a solution of PLLA in dichloromethane. Then the mixture was subject to alternated stirring and ultrasonication to form homogeneous s/o oil slurry. The slurry was added under stirring into a PVA aqueous solution to form the s/o/w emulsion. After 4h of stirring to remove the organic solvent, the solidified microspheres were collected. The drug release characteristics were tested in vitro, and cell proliferation was checked using MG-63 and osteoblast cells. Results and Discussion: MTX/HA/SF microspheres and PLLA-coated MTX/HA/SF microspheres with relatively uniform size and good sphericity were successfully prepared by combining emulsion-solvent evaporation and co-precipitation techniques (Figure 1). The diameter of MTX/HA/SF microspheres could be controlled by changing the concentration of SF solution and stirring speed. The diameter of PLLA-coated MTX/HA/SF microspheres increased with PLLA concentration. FTIR and XRD tests confirmed the formation of HA crystals and effective loading of MTX in both types of microspheres. Compared to the HA/SF microspheres, the PLLA-coated MTX/HA/SF microspheres showed reduced burst release and significantly extended release time (Figure 2). Figure 1. SEM images of (A) MTX/HA/SF microspheres and (B) PLLA-coated MTX/HA/SF microspheres, respectively. Figure 2. Drug release profiles of MTX-loaded HA/SF microspheres in vitro at 37 ºC. Conclusion: In summary, MTX-loaded HA/SF microspheres with good drug package efficiency were successfully prepared. After further coating with PLLA, the microspheres showed low burst release and long-term release capability. Being composed of osteogenic materials and chemotherapy drugs, such a microsphere system is expected to prevent rejuvenation of tumor and in the mean time, to promote bone defect repair. National Natural Science Foundation of China (81171479, 51303120, 81471790); Jiangsu Provincial Special Program of Medical Science (BL2012004); Natural Science Foundation of Jiangsu Province (BK20130335) Keywords: Implant, composite, biomedical application Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016. Presentation Type: Poster Topic: Biomaterials in constructing tissue substitutes Citation: Zhai Q, Zhu C and Li B (2016). Hydroxyapatite/silk fibroin composite microspheres loaded with methotrexate for repairing giant cell tumor-associated bone defects. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02503 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 27 Mar 2016; Published Online: 30 Mar 2016. Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Qingpan Zhai Caihong Zhu Bin Li Google Qingpan Zhai Caihong Zhu Bin Li Google Scholar Qingpan Zhai Caihong Zhu Bin Li PubMed Qingpan Zhai Caihong Zhu Bin Li Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.